Clinical Trial Update: Proteome-based Immunotherapy of Lung Cancer Brain Metastases [Phase 2, Phase 3]

View source ↗

Summary

This update covers a proteome-based immunotherapy trial for brain metastases arising from lung cancer, conducted in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Cancer

Snippet

Sponsor: NeuroVita Clinic | Conditions: Neoplasm Metastasis | Phase 2, Phase 3 | Status: UNKNOWN